MR imaging of the small bowel with increasing concentrations of an oral osmotic agent

European Radiology

Volumn 15, Issue 4, 2005, Pages 666-671

  Borthne, Arne S ^a   Abdelnoor, Michael ^a   Hellund, Johan C ^a   Geitung, J T Jonn T ^a   Storaas, Trygve ^a   Gjesdal, KjellI ^a   Kløw, Nils E ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Gastrografin; Gastrointestinal tract; MR imaging; Osmotic agent; Small bowel

Indexed keywords

CONTRAST MEDIUM; DIATRIZOATE; MEGLUMINE DIATRIZOATE; OSMOTIC AGENT;

ABDOMINAL PAIN; ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE QUALITY; INTESTINE DISTENSION; MALE; NAUSEA; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOLALITY; PALATABILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SMALL INTESTINE; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; CONTRAST MEDIA; FEMALE; HUMANS; INTESTINE, SMALL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PROSPECTIVE STUDIES;

EID: 17044390390     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-004-2636-2     Document Type: Article

References (24)

1. Masselli G, Brizi GM, Parrella A, Minordi LM, Vecchioli A, Mareno P (2004) Crohn disease: Magnetic resonance enteroclysis. Abdom Imaging 29:326-334
2. Schunk K (2002) Small bowel magnetic resonance imaging for inflammatory bowel disease. Top Magn Reson Imaging 13(6):409-425
3. Rieber A, Aschoff A, Nüssle K et al. (2000) MRI in the diagnosis of small bowel disease: Use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 10(9):1377-1382 10.1007/ s003300000354
4. Umschaden HW, Szolar D, Gasser J, Umschaden M, Haselbach H (2000) Small bowel disease: Comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 215:717-725 1:STN:280:DC%2BD3c3ptlCgtQ%3D%3D
5. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Maris T (2000) MR imaging of the small bowel with a true-FISP sequence after enteroclysis with water solution. Invest Radiol 35:707-711
6. Schunk K, Kern A, Oberholzer K, Kalden P, Mayer I, Orth T, Wanitsche R (2000) Hydro-MRI in Crohn's disease: Appraisal of disease activity. Invest Radiol 35:431-437
7. Born C, Nagel B, Leinsiger G, Reiser M (2003) MRI with oral filling in patients with chronic inflammatory bowel diseases. Radiologie 43:34-42
8. Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC (2004) Oral contrast agents for small bowel MRI: Comparison of different additives to optimize bowel distension. Eur Radiol 14(3): 458-464
9. Narin B, Ajaj W, Gohde S et al. (2004) Combined small and large bowel MR imaging in patients with Crohn's disease: A feasibility study. Eur Radiol 18 (Epub ahead of print)
10. Lauenstein TC, Schneemann H, Vogt FM, Herborn CU, Ruhm SG, Debatin JF (2003) Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 228(1):279-283
11. Borthne AS, Dormagen JB, Gjesdal KI, Storaas T, Lygren I, Geitung JT (2003) Bowel MR imaging with oral Gastrografin: An experimental study with healthy volunteers. Eur Radiol 13:100-106
12. Altman DG 1996 Practical statistics for medical research Chapman & Hall London
13. DG Kleinbaum LL Kupper H Morgenstern 1982 Epidemiologic research. Principles and quantitative methods Van Nostrand Reinhold Company New York
14. Donner A, Eliasziw M (1992) A goodness of fit approach to inference procedures for the kappa statistics, confidence interval construction, significance testing and sample size determination, Stat Med 11:1511-1519
15. Vlahos L, Gouliamos A, Athanasopoulou A et al. (1994) A comparative study between Gd-DTPA and oral magnetic particles (OMP) as gastrointestinal (GI) contrast agents for MRI of the abdomen. Magn Reson Imaging 12:719-726
16. Hiraishi K, Narabayashi I, Fujita O et al. (1995) Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging. Radiology 194:119-123
17. Brown JJ (1996) Gastrointestinal contrast agents for MR imaging. MR Clin N Am 4:25-35
18. Burton SS, Liebig T, Frazier SD, Ros PR (1997) High-density oral barium sulfate in abdominal MRI: Efficiency and tolerance in a clinical setting. Magn Reson Imaging 15:147-153
19. Ernst O, Sergent G, L'Hermine C (1997) Oral administration of low-cost negative contrast agent: A three-year experience in routine practice. J Magn Reson Imaging 7:495-498
20. Faber SC, Stehling MK, Holzknecht N, Gauger J, Helmberger T, Reiser M (1997) Pathologic conditions in the small bowel: Findings at fat-suppressed gadolinium-enhanced MR imaging with an optimized suspension of oral magnetic particles. Radiology 205:278-282
21. Small WC, Macchi DD, Parker JR, Bernadino ME (1998) Multisite study of the safety and efficacy of Lumen-Hance, a new gastrointestinal contrast agent for MRI of the abdomen and pelvis. Acad Radiol 5:147-150
22. Debatin JF, Patak MA (1999) MRI of the small and large bowel. Eur Radiol 1523-1534
23. Laniado M, Kornmesser W, Hamm B, Clauss W, Weinmann H-J, Felix R (1988) MR imaging of the gastrointestinal tract: Value of Gd-DTPA. Am J Roentgenol 150:817-821 1:STN:280:BieC28%2FotlU%3D
24. Antes G (2003) Barium examinations of the small intestine and the colon in inflammatory bowel disease. Radiologe 44:9-16